Black Bird Biotech (Black Bird Biotech) Short-Term Capital Lease Obligation : $0.01 Mil (As of Sep. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Black Bird Biotech Short-Term Capital Lease Obligation?

Black Bird Biotech's Short-Term Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.01 Mil.

Black Bird Biotech's quarterly Short-Term Capital Lease Obligation increased from Mar. 2023 ($0.01 Mil) to Jun. 2023 ($0.01 Mil) but then declined from Jun. 2023 ($0.01 Mil) to Sep. 2023 ($0.01 Mil).

Black Bird Biotech Short-Term Capital Lease Obligation Historical Data

The historical data trend for Black Bird Biotech's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Black Bird Biotech Short-Term Capital Lease Obligation Chart

Black Bird Biotech Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

Black Bird Biotech Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	-	0.01	0.01	0.01

Black Bird Biotech Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Black Bird Biotech Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Black Bird Biotech's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Black Bird Biotech (Black Bird Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Black Bird Biotech Inc (OTCPK:BBBT) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

11961 Hilltop Road, Suite 22, Argyle, TX, USA, 76226

Website

https://www.blackbirdpotentials.com

Black Bird Biotech Inc is a licensed grower of industrial hemp under the Montana Hemp Pilot Program. In addition, it is the distributor in the U. S. and Canada for MiteXstream, an EPA-registered plant-based biopesticide effective in the eradication of spider mites, a pest that destroys crops, especially cannabis, hops, coffee, and house plants, as well as molds and mildew. Its products include MiteXstream Biopesticide, Grizzly Creek Naturals, and Black Bird American Hemp.

Executives

Jeffrey A Collins	director, 10 percent owner, officer: President	302 WASHINGTON ST., #513, SAN DIEGO CA 92103
Robert Edward Shea	director, 10 percent owner, officer: President, CEO, CFO, CAO	40 WARREN STREET, 3RD FLOOR, CHARLESTOWN MA 02129
John James Sutherland	director, 10 percent owner, officer: President, CEO, CFO & CAO	C/O SUITE 810 - 675 WEST HASTINGS STREET, VANCOUVER A1 V6B 1N2